Efficacy and safety of high-intensity focused ultrasound ablation for hepatocellular carcinoma by changing the acoustic environment: microbubble contrast agent (SonoVue) and transcatheter arterial chemoembolization

References

• Are C, Meyer B, Stack A, et al. Global trends in the burden of liver cancer. J Surg Oncol. 2017;115:591–602.
   PubMed Web of Science ®Google Scholar
• Kudo M. Surveillance, diagnosis, treatment, and outcome of liver cancer in Japan. Liver Cancer. 2015;4:39–50.
   PubMed Web of Science ®Google Scholar
• Chen X, Liu HP, Li M, et al. Advances in non-surgical management of primary liver cancer. World J Gastroenterol. 2014;20:16630–16638.
   PubMed Web of Science ®Google Scholar
• Padhya KT, Marrero JA, Singal AG. Recent advances in the treatment of hepatocellular carcinoma. Curr Opin Gastroenterol. 2013;29:285–292.
   PubMed Web of Science ®Google Scholar
• Yu H, Burke CT. Comparison of percutaneous ablation technologies in the treatment of malignant liver tumors. Semin Intervent Radiol. 2014;31:129–137.
   PubMed Web of Science ®Google Scholar
• Kennedy JE. High-intensity focused ultrasound in the treatment of solid tumours. Nat Rev Cancer. 2005;5:321–327.
   PubMed Web of Science ®Google Scholar
• Liu L, Xiao Z, Xiao Y, et al. Combination of high-intensity focused ultrasound irradiation and hydroxyapatite nanoparticle injection to injure normal goat liver tissue in vivo without costal bone incision. Genet Mol Res. 2014;13:8301–8308.
   PubMed Web of Science ®Google Scholar
• Ministry of Health of the People’s Republic of China. Standard Specification for diagnosis and treatment of primary Liver cancer (2011). J Clin Oncol. 2011;16:929–946. [Article in Chinese].
   Google Scholar
• Wu F, Chen WZ, Bai J, et al. Pathological changes in human malignant carcinoma treated with high-intensity focused ultrasound. Ultrasound Med Biol. 2001;27:1099–10106.
   PubMed Web of Science ®Google Scholar
• Wu F, Wang ZB, Chen WZ, et al. Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization. Radiology. 2005;235:659–667.
   PubMed Web of Science ®Google Scholar
• Jung SE, Cho SH, Jang JH, et al. High-intensity focused ultrasound ablation in hepatic and pancreatic cancer: complications. Abdom Imaging. 2011;36:185–195.
   PubMedGoogle Scholar
• Zhang L, Zhu H, Jin C, et al. High intensity focused ultrasound (HIFU): effective and safe therapy for hepatocellular carcinoma adjacent to major hepatic veins. Eur Radiol. 2009;19:437–445.
   PubMed Web of Science ®Google Scholar
• Luo W, Zhou X, Ren X, et al. Enhancing effects of SonoVue, a microbubble sonographic contrast agent, on high-intensity focused ultrasound ablation in rabbit livers in vivo. J Ultrasound Med. 2007;26:469–476.
   PubMed Web of Science ®Google Scholar
• Chen Y, Jiang J, Zeng Y, et al. Effects of a microbubble ultrasound contrast agent on high-intensity focused ultrasound for uterine fibroids: a randomised controlled trial. Int J Hyperthermia. 2018;34:1311–1315.
   PubMed Web of Science ®Google Scholar
• Chinese Medical Association. Clinical application guide for high-intensity focused ultrasound tumor therapy system (trial). Natl Chin J Med. 2005;85:796–798. [Article in Chinese].
   Google Scholar
• Cheung TT, Fan ST, Chan SC, et al. High-intensity focused ultrasound ablation: an effective bridging therapy for hepatocellular carcinoma patients. World J Gastroenterol. 2013;19:3083–3089.
   PubMed Web of Science ®Google Scholar
• Liu Z, Gong C, Liu Y, et al. Establishment of a scoring system for predicting the difficulty level of high-intensity focussed ultrasound ablation of uterine fibroids. Int J Hyperthermia. 2018;34:77–86.
   PubMed Web of Science ®Google Scholar
• Cheng SQ, Zhou XD, Tang ZY, et al. Iodized oil enhances the thermal effect of high-intensity focused ultrasound on ablating experimental liver cancer. J Cancer Res Clin Oncol. 1997;123:639–644.
   PubMed Web of Science ®Google Scholar
• Chen C, Liu Y, Maruvada S, et al. Effect of ethanol injection on cavitation and heating of tissues exposed to high-intensity focused ultrasound. Phys Med Biol. 2012;57:937–961.
   PubMed Web of Science ®Google Scholar
• Wang S, Yang C, Zhang J, et al. First experience of high-intensity focused ultrasound combined with transcatheter arterial embolization as local control for hepatoblastoma. Hepatology. 2014;59:170–177.
   PubMed Web of Science ®Google Scholar
• Jiang N, Xie B, Zhang X, et al. Enhancing ablation effects of a microbubble-enhancing contrast agent (“SonoVue”) in the treatment of uterine fibroids with high-intensity focused ultrasound: a randomized controlled trial. Cardiovasc Intervent Radiol. 2014;37:1321–1328.
   PubMed Web of Science ®Google Scholar
• Kim J, Chung DJ, Jung SE, et al. Therapeutic effect of high-intensity focused ultrasound combined with transarterial chemoembolisation for hepatocellular carcinoma <5 cm: comparison with transarterial chemoembolisation monotherapy—preliminary observations. Br J Radiol. 2012;85:940–946.
   PubMed Web of Science ®Google Scholar
• Wu Y, Li J, Zhang SJ, et al. [Clinical observation on high intensity focused ultrasound combined with transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma.]. Zhonghua Wai Ke Za Zhi. 2012;50:691–694. [Article in Chinese].
   PubMedGoogle Scholar
• Zhao J, Zhang H, Wei L, et al. Comparing the long-term efficacy of standard and combined minimally invasive procedures for unresectable HCC: a mixed treatment comparison. Oncotarget. 2017;8:15101–15113.
   PubMedGoogle Scholar
• Chung DJ, Cho SH, Lee JM, et al. Effect of microbubble contrast agent during high intensity focused ultrasound ablation on rabbit liver in vivo. Eur J Radiol. 2012;81:519–523.
   PubMed Web of Science ®Google Scholar
• Kopechek JA, Park EJ, Zhang YZ, et al. Cavitation-enhanced MR-guided focused ultrasound ablation of rabbit tumors in vivo using phase shift nanoemulsions. Phys Med Biol. 2014;59:3465–3481.
   PubMed Web of Science ®Google Scholar
• Leon-Villapalos J, Kaniorou-Larai M, Dziewulski P. Full thickness abdominal burn following magnetic resonance guided focused ultrasound therapy. Burns. 2005;31:1054–1055.
   PubMed Web of Science ®Google Scholar
• Peng S, Hu L, Chen W, et al. Intraprocedure contrast enhanced ultrasound: The value in assessing the effect of ultrasound-guided high intensity focused ultrasound ablation for uterine fibroids. Ultrasonics. 2015;58:123–128.
   PubMed Web of Science ®Google Scholar
• Orsi F, Monfardini L, Bonomo G, et al. Ultrasound guided high intensity focused ultrasound (USgHIFU) ablation for uterine fibroids: Do we need the microbubbles? Int J Hyperthermia. 2015;31:233–239.
   PubMed Web of Science ®Google Scholar
• Cheng CQ, Zhang RT, Xiong Y, et al. Contrast-enhanced ultrasound for evaluation of high-intensity focused ultrasound treatment of benign uterine diseases: retrospective analysis of contrast safety. Medicine (Baltimore). 2015;94:729.
   PubMed Web of Science ®Google Scholar
• Jingqi W, Lu Z, Jun Z, et al. Clinical usefulness of the microbubble contrast agent SonoVue in enhancing the effects of high-intensity focused ultrasound for the treatment of adenomyosis. J Ultrasound Med. 2018;37(12):2811–2819.
   Web of Science ®Google Scholar
• ter Haar G, Sinnett D, Rivens I. High intensity focused ultrasound-a surgical technique for the treatment of discrete liver tumours. Phys Med Biol. 1989;34:1743–1750.
   PubMed Web of Science ®Google Scholar
• Wang Z, Bai J, Li F, et al. Study of a "biological focal region" of high-intensity focused ultrasound. Ultrasound Med Biol. 2003;29:749–754.
   PubMed Web of Science ®Google Scholar
• Chen MS, Li JQ, Zhang YQ, et al. High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma. World J Gastroenterol. 2002;8:74–78.
   PubMed Web of Science ®Google Scholar
• Miyayama S, Matsui O, Yamashiro M, et al. Iodized oil accumulation in the hypovascular tumor portion of early-stage hepatocellular carcinoma after ultraselective transcatheter arterial chemoembolization. Hepatol Int. 2007;1:451–459.
   PubMed Web of Science ®Google Scholar
• Chen CS, Li FK, Guo CY, et al. Tumor vascularity and lipiodol deposition as early radiological markers for predicting risk of disease progression in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization. Oncotarget. 2016;7:7241–7252.
   PubMedGoogle Scholar